🇺🇸 FDA

Company profile · Sponsor

Merck

Merck KGaA, Darmstadt, Germany

E697CFC · NMPA pharma CN
Pipeline
24
Drugs
12
Patents
0

Quick answer

Merck (E697CFC) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 12 drugs, and 0 patents to this profile..

Company facts

Ticker E697CFC
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. Clesrovimab

    Merck

    Respiratory Syncytial Virus Infection

    phase 3 mab completed

    1 trial

  2. DOR/ISL

    Merck

    HIV Infection

    phase 3 small molecule active

    1 trial

  3. IV Tulisokibart

    Merck

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  4. IV Tulisokibart

    Merck

    Crohn's Disease

    phase 3 small molecule active

    1 trial

  5. Lenvatinib

    Merck

    Carcinoma, Hepatocellular

    phase 3 small molecule completed

    1 trial

  6. MK-8527

    Merck

    Human Immunodeficiency Virus (HIV)

    phase 3 small molecule active

    1 trial

  7. Molnupiravir

    Merck

    Coronavirus Disease (COVID-19)

    phase 3 small molecule active

    2 trials

  8. Nemtabrutinib

    Merck

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  9. Pembrolizumab

    Merck

    Metastatic Esophageal Squamous Cell Carcinoma

    phase 3 mab active

    1 trial

  10. Pembrolizumab

    Merck

    Ovarian Cancer

    phase 3 mab completed

    1 trial

  11. Pembrolizumab

    Merck

    Urinary Bladder Neoplasms

    phase 3 small molecule active

    1 trial

  12. Pembrolizumab

    Merck

    Renal Cell Carcinoma

    phase 3 mab completed

    1 trial

  13. Pembrolizumab

    Merck

    Carcinoma, Renal Cell

    phase 3 mab active

    1 trial

  14. Pembrolizumab

    Merck

    Cervical Cancer

    phase 3 mab completed

    1 trial

  15. Pembrolizumab

    Merck

    Solid Tumors

    phase 3 small molecule active

    1 trial

  16. Pembrolizumab

    Merck

    Triple Negative Breast Neoplasms

    phase 3 mab completed

    1 trial

  17. Pembrolizumab

    Merck

    Endometrial Neoplasms

    phase 3 mab active

    1 trial

  18. Pembrolizumab

    Merck

    Gastric Neoplasms

    phase 3 mab completed

    1 trial

  19. Pembrolizumab (K)

    Merck

    Breast Cancer

    phase 3 mab active

    1 trial

  20. Pembrolizumab/Vibostolimab

    Merck

    Lung Neoplasms

    phase 3 mab completed

    1 trial

  21. Prevnar 13™

    Merck

    Pneumococcal Infections

    phase 3 mab completed

    1 trial

  22. Recombinant human luteinizing hormone (r-hLH)

    Merck

    Hypogonadism

    phase 3 small molecule completed

    1 trial

  23. Sacituzumab tirumotecan

    Merck

    Breast Neoplasms

    phase 3 small molecule active

    1 trial

  24. Sacituzumab tirumotecan

    Merck

    Non Small Cell Lung Cancer

    phase 3 mab active

    1 trial

Drugs (12)

Search drugs →

  1. avelumab

    BAVENCIO

    INJECTION approved

    L01FF04

  2. belzutifan

    WELIREG

    ORAL approved

    L01XX74

  3. cetrorelix

    CETROTIDE

    H01CC02

  4. cetuximab

    ERBITUX

    INTRAVENOUS approved

    L01FE01

  5. choriogonadotropin alfa

    OVIDREL

    INJECTION approved

    G03GA08

  6. cladribine

    CLADRITAB

    INJECTION approved

    L04AA40

  7. follitropin alfa

    BEMFOLA

    G03GA05

  8. follitropin alfa + lutropin alfa

    PERGOVERIS

  9. ivermectin

    STROMECTOL

    TOPICAL approved

  10. lutropin alfa

    LUVERIS

    G03GA07

  11. molnupiravir

    LAGEVRIO

    J05A

  12. mycobacterium bovis bcg tice strain

    ONCOTICE

Frequently asked questions

What is Merck?

Merck (E697CFC) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 12 drugs, and 0 patents to this profile..

What pipeline programs does Merck sponsor?

We track 24 ClinicalTrials.gov-linked programs for Merck, including Clesrovimab and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Merck company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.